Press Release

Written by | May 19, 2026

Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease

Further reading

Press Release

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease

Read the Press Release

Press Release

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease

Read the Press Release

Press Release

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease

Read the Press Release

Poster

Smartphone-based measurement of keystroke dynamics in the Phase 2b LUMA in Parkinson’s disease

AD/PD Conference, Poster P3105, 17-21 March 2026, Copenhagen, Denmark

Read Poster

Poster

Smartphone-based measurement of keystroke dynamics in the Phase 2b LUMA in Parkinson’s disease

AD/PD Conference, Poster P3105, 17-21 March 2026, Copenhagen, Denmark

Read Poster

Poster

Smartphone-based measurement of keystroke dynamics in the Phase 2b LUMA in Parkinson’s disease

AD/PD Conference, Poster P3105, 17-21 March 2026, Copenhagen, Denmark

Read Poster

Poster

Assessing Dynamic Difficulty Adjustment in Personalized Testing of Patients with Mild Cognitive Impairment - The ADAPT-MCI-01 Study

AD/PD Conference, Oral Presentation, 17th March 2026, Copenhagen, Denmark

Read Poster

Poster

Assessing Dynamic Difficulty Adjustment in Personalized Testing of Patients with Mild Cognitive Impairment - The ADAPT-MCI-01 Study

AD/PD Conference, Oral Presentation, 17th March 2026, Copenhagen, Denmark

Read Poster

Poster

Assessing Dynamic Difficulty Adjustment in Personalized Testing of Patients with Mild Cognitive Impairment - The ADAPT-MCI-01 Study

AD/PD Conference, Oral Presentation, 17th March 2026, Copenhagen, Denmark

Read Poster